SAT0142 Predictors of Inadequate Response and Rapid Radiographic Progression in Patients With Early Rheumatoid Arthritis Receiving Methotrexate: A Post Hoc Analysis of 2 Randomized, Controlled Trials of Adalimumab

doi 10.1136/annrheumdis-2017-eular.1892
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ Publishing Group Ltd and European League Against Rheumatism

Related search

Predictors of Pneumonia on Routine Chest Radiographs in Patients With COPD: A Post Hoc Analysis of Two 1-Year Randomized Controlled Trials

International Journal of COPD
EnvironmentalPublic HealthHealth PolicyMedicinePulmonaryRespiratory MedicineOccupational Health
2018English

Achieving Comprehensive Disease Control in Patients With Early and Established Rheumatoid Arthritis Treated With Adalimumab Plus Methotrexate Versus Methotrexate Alone

RMD Open
RheumatologyAllergyImmunology
2017English

Adalimumab With or Without Methotrexate in Juvenile Rheumatoid Arthritis

New England Journal of Medicine
Medicine
2008English

Increase in Methotrexate Dose in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Infliximab

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
2005English

Effect of Ertugliflozin on Blood Pressure in Patients With Type 2 Diabetes Mellitus: A Post Hoc Pooled Analysis of Randomized Controlled Trials

Cardiovascular Diabetology
Internal MedicineCardiologyEndocrinologyCardiovascular MedicineMetabolismDiabetes
2019English

Efficacy and Safety of Tofacitinib in Japanese Patients With Rheumatoid Arthritis by Background Methotrexate Dose: A Post-Hoc Analysis of Clinical Trial Data

Modern Rheumatology
MedicineRheumatology
2019English

Efficacy and Safety of Baricitinib for Active Rheumatoid Arthritis in Patients With an Inadequate Response to Conventional Synthetic or Biological Disease‑modifying Anti‑rheumatic Drugs: A Meta‑analysis of Randomized Controlled Trials

Experimental and Therapeutic Medicine
MedicineCancer ResearchImmunologyMicrobiology
2018English

Peficitinib, a JAK Inhibitor, in the Treatment of Moderate-To-Severe Rheumatoid Arthritis in Patients With an Inadequate Response to Methotrexate

Arthritis and Rheumatology
RheumatologyAllergyImmunology
2017English

Adalimumab in the Treatment of Early Rheumatoid Arthritis

Nauchno-Prakticheskaya Revmatologiya
RheumatologyAllergyImmunology
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy